著名的英国医学杂志《柳叶刀》早在2022年2月4日就发表Peter Nordström(彼得·诺兹特儒姆)博士等人的论文“Risk of infection, hospitalization, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden”,中文为《瑞典的一项回顾性批量人口...
Two doses of an mRNA COVID-19 vaccine slashes COVID-19-related hospitalizations and emergency department (ED) visits in kids aged 6 months to 4 years by 40%, according to anew studyby the Centers for Disease Control and Prevention (CDC). METHODOLOGY: SARS-CoV-2 infection can severely affe...
13.Lee SG,Park GU.Clinical characteristics and risk factors for fatality and severity in patients with coronavirus disease in korea:a nationwide population-based retrospective study using the Korean Health Insurance Review and Assessment Service (HIRA)...
et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum. Infect. Dis. 9, ofac464 (2022). 20. Taquet, M., Dercon, Q. & Harrison, P. J. ...
A study shows that US children who received mRNA COVID-19 vaccines have some protection against developing long-lasting symptoms of the coronavirus SARS-CoV-2. By Shannon Hall Twitter Facebook Email Vaccinated children are less likely than unvaccinated children to develop long COVID, the myriad ...
[7] Villar J, Soto Conti CP, Gunier RB, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, prospective cohort study. Lancet 2023...
et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum. Infect. Dis. 9, ofac464 (2022). 20. Taquet, M., Dercon, Q. & Harrison, P. J. ...
Long COVID still a risk, even for vaccinated people COVID-19 vaccines can lower the risk of death by 34% and long COVID by 15% compared to the unvaccinated with SARS-CoV-2 infections, a new study ha…
[46]He T, Zhou Y, Xu P, et al. Safety and antibody response toinactivated COVID-19 vaccine in patients with chronic hepatitisB virus infection[J]. Liver Int, 2022 Feb 2. DOI: 10.1111/liv.15173. [47]Wang J, ...
Then come much larger phase 3 trials, which study tens of thousands of patients for both effectiveness and safety. If things still look good at that point, a vaccine can be submitted to the FDA for review and potential release. ...